Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway

Abstract There is lack of knowledge about the safety of treatment with methadone and buprenorphine as part of opioid maintenance treatment (OMT) during pregnancy. The purpose of this study was to examine neonatal outcomes concerning the use of OMT during pregnancy. We used nationwide registry linkag...

Full description

Bibliographic Details
Main Authors: Marte Handal, Blanka Nechanská, Svetlana Skurtveit, Ingunn Olea Lund, Roman Gabrhelík, Anders Engeland, Viktor Mravčík
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.501
_version_ 1818865927551188992
author Marte Handal
Blanka Nechanská
Svetlana Skurtveit
Ingunn Olea Lund
Roman Gabrhelík
Anders Engeland
Viktor Mravčík
author_facet Marte Handal
Blanka Nechanská
Svetlana Skurtveit
Ingunn Olea Lund
Roman Gabrhelík
Anders Engeland
Viktor Mravčík
author_sort Marte Handal
collection DOAJ
description Abstract There is lack of knowledge about the safety of treatment with methadone and buprenorphine as part of opioid maintenance treatment (OMT) during pregnancy. The purpose of this study was to examine neonatal outcomes concerning the use of OMT during pregnancy. We used nationwide registry linkages from the Czech Republic (2000‐2014) and Norway (2004‐2013). We compared prenatally OMT–exposed newborns with (a) newborns of women hospitalized with opioid use disorder during pregnancy in the Czech sample and (b) newborns with neonatal abstinence syndrome (NAS) in Norway. We performed multivariate linear and binary logistic regression exploring the associations between OMT and neonatal outcomes (growth parameters, gestational age, fetal death, small for gestational age, Apgar score, and NAS). Regression coefficients (b) and odds ratios (ORs) were estimated. The cohorts consisted of 333 Czech, and 235 Norwegian OMT–exposed newborns, and 106 and 294 newborns in the comparison groups, respectively. In both countries, the neonatal growth parameters were similar in the OMT and the comparison groups. In Norway, OMT exposure prolonged gestational age (adjusted b = 0.96 weeks, 95% confidence interval [CI] =0.39‐1.53) while the odds of preterm birth and Apgar score at 5 minutes were lower than in the comparison group (adjusted OR = 0.35, 0.16‐0.75 and aOR = 0.21, 0.06‐0.78, respectively). Newborns of women in OMT had similar growth parameters as newborns of women with opioid use disorders who were not in OMT during pregnancy. Overall, our findings do not suggest that OMT results in worse neonatal outcomes.
first_indexed 2024-12-19T10:55:20Z
format Article
id doaj.art-5aaae5f5ce114785af061ffe6db292ca
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-12-19T10:55:20Z
publishDate 2019-10-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-5aaae5f5ce114785af061ffe6db292ca2022-12-21T20:24:49ZengWileyPharmacology Research & Perspectives2052-17072019-10-0175n/an/a10.1002/prp2.501Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and NorwayMarte Handal0Blanka Nechanská1Svetlana Skurtveit2Ingunn Olea Lund3Roman Gabrhelík4Anders Engeland5Viktor Mravčík6Department of Mental Disorders Norwegian Institute of Public Health Oslo NorwayDepartment of Addictology, First Faculty of Medicine Charles University Prague Czech RepublicDepartment of Mental Disorders Norwegian Institute of Public Health Oslo NorwayDepartment of Mental Disorders Norwegian Institute of Public Health Oslo NorwayDepartment of Addictology, First Faculty of Medicine Charles University Prague Czech RepublicDepartment of Chronic Diseases and Ageing Norwegian Institute of Public Health Oslo NorwayDepartment of Addictology, First Faculty of Medicine Charles University Prague Czech RepublicAbstract There is lack of knowledge about the safety of treatment with methadone and buprenorphine as part of opioid maintenance treatment (OMT) during pregnancy. The purpose of this study was to examine neonatal outcomes concerning the use of OMT during pregnancy. We used nationwide registry linkages from the Czech Republic (2000‐2014) and Norway (2004‐2013). We compared prenatally OMT–exposed newborns with (a) newborns of women hospitalized with opioid use disorder during pregnancy in the Czech sample and (b) newborns with neonatal abstinence syndrome (NAS) in Norway. We performed multivariate linear and binary logistic regression exploring the associations between OMT and neonatal outcomes (growth parameters, gestational age, fetal death, small for gestational age, Apgar score, and NAS). Regression coefficients (b) and odds ratios (ORs) were estimated. The cohorts consisted of 333 Czech, and 235 Norwegian OMT–exposed newborns, and 106 and 294 newborns in the comparison groups, respectively. In both countries, the neonatal growth parameters were similar in the OMT and the comparison groups. In Norway, OMT exposure prolonged gestational age (adjusted b = 0.96 weeks, 95% confidence interval [CI] =0.39‐1.53) while the odds of preterm birth and Apgar score at 5 minutes were lower than in the comparison group (adjusted OR = 0.35, 0.16‐0.75 and aOR = 0.21, 0.06‐0.78, respectively). Newborns of women in OMT had similar growth parameters as newborns of women with opioid use disorders who were not in OMT during pregnancy. Overall, our findings do not suggest that OMT results in worse neonatal outcomes.https://doi.org/10.1002/prp2.501buprenorphinemethadoneneonateopioid maintenance treatmentprenatal exposure
spellingShingle Marte Handal
Blanka Nechanská
Svetlana Skurtveit
Ingunn Olea Lund
Roman Gabrhelík
Anders Engeland
Viktor Mravčík
Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
Pharmacology Research & Perspectives
buprenorphine
methadone
neonate
opioid maintenance treatment
prenatal exposure
title Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
title_full Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
title_fullStr Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
title_full_unstemmed Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
title_short Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway
title_sort prenatal exposure to opioid maintenance treatment and neonatal outcomes nationwide registry studies from the czech republic and norway
topic buprenorphine
methadone
neonate
opioid maintenance treatment
prenatal exposure
url https://doi.org/10.1002/prp2.501
work_keys_str_mv AT martehandal prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway
AT blankanechanska prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway
AT svetlanaskurtveit prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway
AT ingunnolealund prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway
AT romangabrhelik prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway
AT andersengeland prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway
AT viktormravcik prenatalexposuretoopioidmaintenancetreatmentandneonataloutcomesnationwideregistrystudiesfromtheczechrepublicandnorway